{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:14:02Z","timestamp":1791252842103,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Imaging"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s40336-014-0051-5","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T06:51:09Z","timestamp":1395125469000},"page":"67-76","source":"Crossref","is-referenced-by-count":67,"title":["The theranostic path to personalized nanomedicine"],"prefix":"10.1007","volume":"2","author":[{"given":"Benjamin","family":"Theek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Y.","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Ehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Kiessling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Twan","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,19]]},"reference":[{"issue":"5","key":"51_CR1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"issue":"1","key":"51_CR2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57\u201370","journal-title":"Cell"},{"issue":"3021","key":"51_CR3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.116.3021.561","volume":"116","author":"JM Essenberg","year":"1952","unstructured":"Essenberg JM (1952) Cigarette smoke and the incidence of primary neoplasm of the lung in the albino mouse. Science 116(3021):561\u2013562","journal-title":"Science"},{"issue":"12","key":"51_CR4","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1002\/ijc.27816","volume":"131","author":"SS Hecht","year":"2012","unstructured":"Hecht SS (2012) Lung carcinogenesis by tobacco smoke. Int J Cancer 131(12):2724\u20132732","journal-title":"Int J Cancer"},{"key":"51_CR5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","volume":"6","author":"ER Fearon","year":"2011","unstructured":"Fearon ER (2011) Molecular genetics of colorectal cancer. Annu Rev Pathol 6:479\u2013507","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"51_CR6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/sj.bjc.6604483","volume":"99","author":"T Lammers","year":"2008","unstructured":"Lammers T, Hennink WE, Storm G (2008) Tumour-targeted nanomedicines: principles and practice. Br J Cancer 99(3):392\u2013397","journal-title":"Br J Cancer"},{"issue":"4","key":"51_CR7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrc2346","volume":"8","author":"RK Jain","year":"2008","unstructured":"Jain RK (2008) Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer. Nat Rev Cancer 8(4):309\u2013316","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"51_CR8","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1021\/mp200394t","volume":"8","author":"R Duncan","year":"2011","unstructured":"Duncan R, Gaspar R (2011) Nanomedicine(s) under the microscope. Mol Pharm 8(6):2101\u20132141","journal-title":"Mol Pharm"},{"issue":"13\u201314","key":"51_CR9","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.addr.2013.09.018","volume":"65","author":"S Kunjachan","year":"2013","unstructured":"Kunjachan S, Rychlik B, Storm G, Kiessling F, Lammers T (2013) Multidrug resistance: physiological principles and nanomedical solutions. Adv Drug Deliv Rev 65(13\u201314):1852\u20131865","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"51_CR10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","volume":"161","author":"T Lammers","year":"2012","unstructured":"Lammers T, Kiessling F, Hennink WE, Storm G (2012) Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release 161(2):175\u2013187","journal-title":"J Control Release"},{"issue":"11","key":"51_CR11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","volume":"7","author":"RK Jain","year":"2010","unstructured":"Jain RK, Stylianopoulos T (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7(11):653\u2013664","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"51_CR12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.addr.2012.08.012","volume":"65","author":"R Duncan","year":"2013","unstructured":"Duncan R, Vicent MJ (2013) Polymer therapeutics-prospects for 21st century: the end of the beginning. Adv Drug Deliv Rev 65(1):60\u201370","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"51_CR13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"TM Allen","year":"2013","unstructured":"Allen TM, Cullis PR (2013) Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65(1):36\u201348","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"51_CR14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1021\/ar200019c","volume":"44","author":"T Lammers","year":"2011","unstructured":"Lammers T, Aime S, Hennink WE, Storm G, Kiessling F (2011) Theranostic nanomedicine. Acc Chem Res 44(10):1029\u20131038","journal-title":"Acc Chem Res"},{"issue":"6","key":"51_CR15","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.copbio.2013.02.020","volume":"24","author":"LY Rizzo","year":"2013","unstructured":"Rizzo LY, Theek B, Storm G, Kiessling F, Lammers T (2013) Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. Curr Opin Biotechnol 24(6):1159\u20131166","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"51_CR16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.addr.2012.10.014","volume":"65","author":"J Kopecek","year":"2013","unstructured":"Kopecek J (2013) Polymer-drug conjugates: origins, progress to date and future directions. Adv Drug Deliv Rev 65(1):49\u201359","journal-title":"Adv Drug Deliv Rev"},{"key":"51_CR17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-040210-162544","volume":"63","author":"AZ Wang","year":"2012","unstructured":"Wang AZ, Langer R, Farokhzad OC (2012) Nanoparticle delivery of cancer drugs. Annu Rev Med 63:185\u2013198","journal-title":"Annu Rev Med"},{"issue":"1","key":"51_CR18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","volume":"13","author":"AD Bangham","year":"1965","unstructured":"Bangham AD, Standish MM, Watkins JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13(1):238\u2013252","journal-title":"J Mol Biol"},{"issue":"3","key":"51_CR19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0014-5793(73)80394-1","volume":"36","author":"G Gregoriadis","year":"1973","unstructured":"Gregoriadis G (1973) Drug entrapment in liposomes. FEBS Lett 36(3):292\u2013296","journal-title":"FEBS Lett"},{"issue":"5","key":"51_CR20","doi-asserted-by":"crossref","first-page":"58P","DOI":"10.1042\/bj1240058P","volume":"124","author":"G Gregoriadis","year":"1971","unstructured":"Gregoriadis G, Ryman BE (1971) Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochem J 124(5):58P","journal-title":"Biochem J"},{"issue":"1","key":"51_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1517\/17425247.5.1.25","volume":"5","author":"DB Fenske","year":"2008","unstructured":"Fenske DB, Cullis PR (2008) Liposomal nanomedicines. Expert Opin Drug Deliv 5(1):25\u201344","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"51_CR22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-5793(99)01320-4","volume":"460","author":"T Ishida","year":"1999","unstructured":"Ishida T, Iden DL, Allen TM (1999) A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs. FEBS Lett 460(1):129\u2013133","journal-title":"FEBS Lett"},{"issue":"1","key":"51_CR23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","volume":"268","author":"AL Klibanov","year":"1990","unstructured":"Klibanov AL, Maruyama K, Torchilin VP, Huang L (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268(1):235\u2013237","journal-title":"FEBS Lett"},{"issue":"1","key":"51_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.addr.2012.10.002","volume":"65","author":"H Maeda","year":"2013","unstructured":"Maeda H, Nakamura H, Fang J (2013) The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev 65(1):71\u201379","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"51_CR25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2012.04.038","volume":"164","author":"H Maeda","year":"2012","unstructured":"Maeda H (2012) Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J Control Release 164(2):138\u2013144","journal-title":"J Control Release"},{"issue":"2","key":"51_CR26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"Y Barenholz","year":"2012","unstructured":"Barenholz Y (2012) Doxil(R)\u2014the first FDA-approved nano-drug: lessons learned. J Control Release 160(2):117\u2013134","journal-title":"J Control Release"},{"issue":"4","key":"51_CR27","first-page":"987","volume":"54","author":"A Gabizon","year":"1994","unstructured":"Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A, Barenholz Y (1994) Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54(4):987\u2013992","journal-title":"Cancer Res"},{"issue":"4","key":"51_CR28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1517\/17425247.2013.758631","volume":"10","author":"JP May","year":"2013","unstructured":"May JP, Li SD (2013) Hyperthermia-induced drug targeting. Expert Opin Drug Deliv 10(4):511\u2013527","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"51_CR29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.addr.2009.12.005","volume":"62","author":"R Duncan","year":"2010","unstructured":"Duncan R, Vicent MJ (2010) Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities. Adv Drug Deliv Rev 62(2):272\u2013282","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"51_CR30","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrc1958","volume":"6","author":"R Duncan","year":"2006","unstructured":"Duncan R (2006) Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 6(9):688\u2013701","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"51_CR31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cossms.2012.10.003","volume":"16","author":"M Talelli","year":"2012","unstructured":"Talelli M, Rijcken CJ, Hennink W, Lammers T (2012) Polymeric micelles for cancer therapy: 3 C\u2019s to enhance efficacy. Curr Opin Solid State Mater Sci 16(6):302\u2013309","journal-title":"Curr Opin Solid State Mater Sci"},{"key":"51_CR32","doi-asserted-by":"crossref","unstructured":"Hrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T, De Witt D, Figa M, Figueiredo M, Horhota A, Low S, McDonnell K, Peeke E, Retnarajan B, Sabnis A, Schnipper E, Song JJ, Song YH, Summa J, Tompsett D, Troiano G, Van Geen Hoven T, Wright J, LoRusso P, Kantoff PW, Bander NH, Sweeney C, Farokhzad OC, Langer R, Zale S (2012) Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med 4(128):128ra139","DOI":"10.1126\/scitranslmed.3003651"},{"issue":"5","key":"51_CR33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1101\/gad.1047403","volume":"17","author":"TF Massoud","year":"2003","unstructured":"Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17(5):545\u2013580","journal-title":"Genes Dev"},{"issue":"Suppl 1","key":"51_CR34","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0720-048X(12)70005-0","volume":"81","author":"J Bzyl","year":"2012","unstructured":"Bzyl J, Lederle W, Palmowski M, Kiessling F (2012) Molecular and functional ultrasound imaging of breast tumors. Eur J Radiol 81(Suppl 1):S11\u2013S12","journal-title":"Eur J Radiol"},{"issue":"7","key":"51_CR35","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1055\/s-2007-963189","volume":"179","author":"W Stiller","year":"2007","unstructured":"Stiller W, Kobayashi M, Koike K, Stampfl U, Richter GM, Semmler W, Kiessling F (2007) Initial experience with a novel low-dose micro-CT system. Rofo 179(7):669\u2013675","journal-title":"Rofo"},{"issue":"1","key":"51_CR36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/092986707779313516","volume":"14","author":"F Kiessling","year":"2007","unstructured":"Kiessling F, Morgenstern B, Zhang C (2007) Contrast agents and applications to assess tumor angiogenesis in vivo by magnetic resonance imaging. Curr Med Chem 14(1):77\u201391","journal-title":"Curr Med Chem"},{"issue":"3","key":"51_CR37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1593\/neo.03394","volume":"6","author":"F Kiessling","year":"2004","unstructured":"Kiessling F, Farhan N, Lichy MP, Vosseler S, Heilmann M, Krix M, Bohlen P, Miller DW, Mueller MM, Semmler W, Fusenig NE, Delorme S (2004) Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101. Neoplasia 6(3):213\u2013223","journal-title":"Neoplasia"},{"issue":"3","key":"51_CR38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1160\/TH12-10-0721","volume":"109","author":"J Ehling","year":"2013","unstructured":"Ehling J, Lammers T, Kiessling F (2013) Non-invasive imaging for studying anti-angiogenic therapy effects. Thromb Haemost 109(3):375\u2013390","journal-title":"Thromb Haemost"},{"issue":"10","key":"51_CR39","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1021\/ar200084x","volume":"44","author":"C Tassa","year":"2011","unstructured":"Tassa C, Shaw SY, Weissleder R (2011) Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res 44(10):842\u2013852","journal-title":"Acc Chem Res"},{"issue":"34","key":"51_CR40","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1016\/j.biomaterials.2012.08.036","volume":"33","author":"J Jayapaul","year":"2012","unstructured":"Jayapaul J, Arns S, Lederle W, Lammers T, Comba P, Gatjens J, Kiessling F (2012) Riboflavin carrier protein-targeted fluorescent USPIO for the assessment of vascular metabolism in tumors. Biomaterials 33(34):8822\u20138829","journal-title":"Biomaterials"},{"issue":"9","key":"51_CR41","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1007\/s00330-011-2138-y","volume":"21","author":"J Bzyl","year":"2011","unstructured":"Bzyl J, Lederle W, Rix A, Grouls C, Tardy I, Pochon S, Siepmann M, Penzkofer T, Schneider M, Kiessling F, Palmowski M (2011) Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38). Eur Radiol 21(9):1988\u20131995","journal-title":"Eur Radiol"},{"issue":"2","key":"51_CR42","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00330-012-2594-z","volume":"23","author":"J Bzyl","year":"2013","unstructured":"Bzyl J, Palmowski M, Rix A, Arns S, Hyvelin JM, Pochon S, Ehling J, Schrading S, Kiessling F, Lederle W (2013) The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55). Eur Radiol 23(2):468\u2013475","journal-title":"Eur Radiol"},{"issue":"1","key":"51_CR43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1158\/1535-7163.MCT-07-0409","volume":"7","author":"M Palmowski","year":"2008","unstructured":"Palmowski M, Huppert J, Ladewig G, Hauff P, Reinhardt M, Mueller MM, Woenne EC, Jenne JW, Maurer M, Kauffmann GW, Semmler W, Kiessling F (2008) Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther 7(1):101\u2013109","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"51_CR44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2967\/jnumed.111.099754","volume":"53","author":"F Kiessling","year":"2012","unstructured":"Kiessling F, Fokong S, Koczera P, Lederle W, Lammers T (2012) Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics. J Nucl Med 53(3):345\u2013348","journal-title":"J Nucl Med"},{"issue":"5","key":"51_CR45","doi-asserted-by":"crossref","first-page":"e63857","DOI":"10.1371\/journal.pone.0063857","volume":"8","author":"TA Burgers","year":"2013","unstructured":"Burgers TA, Hoffmann MF, Collins CJ, Zahatnansky J, Alvarado MA, Morris MR, Sietsema DL, Mason JJ, Jones CB, Ploeg HL, Williams BO (2013) Mice lacking pten in osteoblasts have improved intramembranous and late endochondral fracture healing. PLoS ONE 8(5):e63857","journal-title":"PLoS ONE"},{"issue":"4","key":"51_CR46","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/138920112799436302","volume":"13","author":"S Kunjachan","year":"2012","unstructured":"Kunjachan S, Jayapaul J, Mertens ME, Storm G, Kiessling F, Lammers T (2012) Theranostic systems and strategies for monitoring nanomedicine-mediated drug targeting. Curr Pharm Biotechnol 13(4):609\u2013622","journal-title":"Curr Pharm Biotechnol"},{"key":"51_CR47","doi-asserted-by":"crossref","unstructured":"Kiessling F, Mertens ME, Grimm J, Lammers T (2014) Nanoparticles for imaging: top or flop? Radiology (in press)","DOI":"10.1148\/radiol.14131520"},{"issue":"2","key":"51_CR48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jconrel.2012.01.027","volume":"161","author":"AM Nystrom","year":"2012","unstructured":"Nystrom AM, Fadeel B (2012) Safety assessment of nanomaterials: implications for nanomedicine. J Control Release 161(2):403\u2013408","journal-title":"J Control Release"},{"issue":"1","key":"51_CR49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2214\/ajr.152.1.167","volume":"152","author":"R Weissleder","year":"1989","unstructured":"Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 152(1):167\u2013173","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"51_CR50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2214\/ajr.152.1.175","volume":"152","author":"R Weissleder","year":"1989","unstructured":"Weissleder R, Elizondo G, Stark DD, Hahn PF, Marfil J, Gonzalez JF, Saini S, Todd LE, Ferrucci JT (1989) The diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide. AJR Am J Roentgenol 152(1):175\u2013180","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"51_CR51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1162\/15353500200505145","volume":"4","author":"M Modo","year":"2005","unstructured":"Modo M, Hoehn M, Bulte JW (2005) Cellular MR imaging. Mol Imaging 4(3):143\u2013164","journal-title":"Mol Imaging"},{"issue":"1","key":"51_CR52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1148\/radiol.12112212","volume":"265","author":"M Gorelik","year":"2012","unstructured":"Gorelik M, Orukari I, Wang J, Galpoththawela S, Kim H, Levy M, Gilad AA, Bar-Shir A, Kerr DA, Levchenko A, Bulte JW, Walczak P (2012) Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor. Radiology 265(1):175\u2013185","journal-title":"Radiology"},{"issue":"11","key":"51_CR53","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrclinonc.2011.141","volume":"8","author":"MF Kircher","year":"2011","unstructured":"Kircher MF, Gambhir SS, Grimm J (2011) Noninvasive cell-tracking methods. Nat Rev Clin Oncol 8(11):677\u2013688","journal-title":"Nat Rev Clin Oncol"},{"issue":"14","key":"51_CR54","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1096\/fj.05-4145fje","volume":"19","author":"WJ Mulder","year":"2005","unstructured":"Mulder WJ, Strijkers GJ, Habets JW, Bleeker EJ, van der Schaft DW, Storm G, Koning GA, Griffioen AW, Nicolay K (2005) MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 19(14):2008\u20132010","journal-title":"FASEB J"},{"issue":"1","key":"51_CR55","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/nn303955n","volume":"7","author":"S Kunjachan","year":"2013","unstructured":"Kunjachan S, Gremse F, Theek B, Koczera P, Pola R, Pechar M, Etrych T, Ulbrich K, Storm G, Kiessling F, Lammers T (2013) Noninvasive optical imaging of nanomedicine biodistribution. ACS Nano 7(1):252\u2013262","journal-title":"ACS Nano"},{"issue":"6","key":"51_CR56","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1200\/JCO.20.6.1668","volume":"20","author":"LW Seymour","year":"2002","unstructured":"Seymour LW, Ferry DR, Anderson D, Hesslewood S, Julyan PJ, Poyner R, Doran J, Young AM, Burtles S, Kerr DJ (2002) Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. J Clin Oncol 20(6):1668\u20131676","journal-title":"J Clin Oncol"},{"issue":"2","key":"51_CR57","first-page":"243","volume":"7","author":"KJ Harrington","year":"2001","unstructured":"Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters AM, Vile RG, Stewart JS (2001) Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res 7(2):243\u2013254","journal-title":"Clin Cancer Res"},{"key":"51_CR58","unstructured":"Celsion Corp (2013) Thermodox\u2014within a program. http:\/\/celsion.com\/docs\/pipeline_overview . Accessed 9 Oct 2013"},{"issue":"2","key":"51_CR59","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jconrel.2012.04.041","volume":"161","author":"H Grull","year":"2012","unstructured":"Grull H, Langereis S (2012) Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. J Control Release 161(2):317\u2013327","journal-title":"J Control Release"},{"issue":"18","key":"51_CR60","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1158\/1078-0432.CCR-12-1414","volume":"18","author":"T Lammers","year":"2012","unstructured":"Lammers T, Rizzo LY, Storm G, Kiessling F (2012) Personalized nanomedicine. Clin Cancer Res 18(18):4889\u20134894","journal-title":"Clin Cancer Res"},{"key":"51_CR61","doi-asserted-by":"crossref","unstructured":"Harris L, Batist G, Belt R, Rovira D, Navari R, Azarnia N, Welles L, Winer E, Group TDS (2002) Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma. Cancer 94(1):25\u201336","DOI":"10.1002\/cncr.10201"},{"issue":"5","key":"51_CR62","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0936-6555(05)80269-9","volume":"6","author":"ND James","year":"1994","unstructured":"James ND, Coker RJ, Tomlinson D, Harris JR, Gompels M, Pinching AJ, Stewart JS (1994) Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi\u2019s sarcoma in AIDS. Clin Oncol (R Coll Radiol) 6(5):294\u2013296","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"7","key":"51_CR63","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.1998.16.7.2445","volume":"16","author":"DW Northfelt","year":"1998","unstructured":"Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A, Kaplan LD, Du Mond C, Mamelok RD, Henry DH (1998) Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi\u2019s sarcoma: results of a randomized phase III clinical trial. J Clin Oncol 16(7):2445\u20132451","journal-title":"J Clin Oncol"}],"container-title":["Clinical and Translational Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40336-014-0051-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40336-014-0051-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40336-014-0051-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T15:16:48Z","timestamp":1565277408000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40336-014-0051-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1007\/s40336-014-0051-5","relation":{},"ISSN":["2281-5872","2281-7565"],"issn-type":[{"value":"2281-5872","type":"print"},{"value":"2281-7565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}